This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Audrey Parat, PhD
Project Chemist at PolyPeptide Group

Profile

Audrey studied at the University of Avignon in France, where she received a MSc in chemistry in 2004. She completed a Ph.D. in the development of peptide bioconjugates for the Multiple Sclerosis treatment in 2008. Then, she moved to the group of Prof. Pierre Schaaf at the Institut Charles Sadron in Strasbourg University, for a post-doctoral work on the synthesis of biomaterials (nanoparticles for diabetes type I treatment and biofilms for skin regeneration). She joined Delphine Felder-Flesch group for 5 years at IPCMS in developing probes for melanoma diagnosis. In 2018, Audrey joined Poly Peptide Laboratories Strasbourg as Project Chemist where her work is focused on developing new peptide production processes for both non-GMP and GMP applications.

Agenda Sessions

  • A Cocktail of Multi PEGylated Peptides - A Case Study in Peptide GMP Process Development

    10:30